The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
Open accessAbstract
The treatment of advanced ovarian cancer with taxol is hindered by the development of drug resistance. The cellular target for taxol is the microtubule that is stabilized by the drug. Taxol preferentially binds to the beta subunit of tubulin of which there are six distinct isotypes in mammalian cells. We have used highly specific oligonucleotides and polymerase chain reaction to analyze expression of all six beta-tubulin genes. Human lung cancer cells (A549) were selected in 12 and 24 nM taxol resulting in cell lines that were 9- and 17-fold resistant, respectively. These cells displayed an altered ratio of classes I, II, III, and IVa beta-tubulin isotypes. Ovarian tumors, seven untreated primary and four taxol- resistant tumor-bearing ascites, displayed significant increases (P < 0.005) in classes I (3.6-fold), III (4.4-fold), and IVa (7.6-fold) isotypes in the taxol-resistant samples as compared with untreated primary ovarian tumors. The increased expression appears to be related to the resistance phenotype, as the basal levels of the class III and IVa isotypes in the untreated tumors were extremely low. This is the first report of altered expression of specific beta-tubulin genes in taxol-resistant ovarian tumors and we propose that the latter may play a role in clinical resistance to taxol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Self-citationParker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1996) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.1.5 · Cited by 1,759
McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., & Donehower, R. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-273 · Cited by 1,100
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
THE IMPACT OF NATIONAL CANCER ACT
(1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797 · Cited by 796
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., & Deeley, R. G. (1994) · PubMed · Cited by 770
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
Holmes, F. A., Walters, R. S., Theriault, R. L., Buzdar, A. U., Frye, D. K., Hortobagyi, G. N., Forman, A. D., Newton, L. K., & Raber, M. N. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797-a · Cited by 746
Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7160 · Cited by 714
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mülder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., & Broxterman, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8822 · Cited by 680
Structure and Utilization of Tubulin Isotypes
Sullivan, K. F. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.003351 · Cited by 474
Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer
Murphy, W. K., Fossella, F. V., Winn, R. J., Shin, D. M., Hynes, H. E., Gross, H. M., Davilla, E., Leimert, J., Dhingra, H., Raber, M. N., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.384 · Cited by 429
Taxol: Mechanisms of Action and Resistancea
HORWITZ, S. B., LOTHSTEIN, L., MANFREDI, J. J., MELLADO, W., PARNESS, J., ROY, S. N., SCHIFF, P. B., SORBARA, L., & ZEHEB, R. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb38455.x · Cited by 416
Self-citationSullivan, K. F., & Cleveland, D. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4327 · Cited by 400
Microtubule dynamics in vitro are regulated by the tubulin isotype composition.
Panda, D., Miller, H. P., Banerjee, A., Ludueña, R. F., & Wilson, L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11358 · Cited by 374
Substoichiometric Binding of Taxol Suppresses Microtubule Dynamics
Derry, W. B., Wilson, L., & Jordan, M. A. (1995) · Biochemistry · doi:10.1021/bi00007a014 · Cited by 335
Five mouse tubulin isotypes and their regulated expression during development.
Lewis, S. A., Lee, M. G., & Cowan, N. J. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.852 · Cited by 314
Alkaline transfer of DNA to plastic membrane
Chomczynski, P., & Qasba, P. K. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90480-7 · Cited by 282
Wang, D., Villasante, A., Lewis, S. A., & Cowan, N. J. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.5.1903 · Cited by 279
Alexander, J. E., Hunt, D. F., Lee, M. K., Shabanowitz, J., Michel, H., Berlin, S. C., MacDonald, T. L., Sundberg, R. J., Rebhun, L. I., & Frankfurter, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4685 · Cited by 267
Are tubulin isotypes functionally significant.
Ludueña, R. F. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.5.445 · Cited by 253
Derry, W. B., Wilson, L., Khan, I. A., Ludueña, R. F., & Jordan, M. A. (1997) · Biochemistry · doi:10.1021/bi962724m · Cited by 252
Characterization of the Taxol Binding Site on the Microtubule
Rao, S., Orr, G. A., Chaudhary, A. G., Kingston, D. G. I., & Horwitz, S. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20235 · Cited by 235
Self-citationFree intermingling of mammalian β-tubulin isotypes among functionally distinct microtubules
Lewis, S. A., Gu, W., & Cowan, N. J. (1987) · Cell · doi:10.1016/0092-8674(87)90456-9 · Cited by 232
Minotti, A. M., Barlow, S. B., & Cabral, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67891-9 · Cited by 221
Taxol: mechanisms of action and resistance.
Horwitz, S. B., Cohen, D., Rao, S., Ringel, I., Hj, S., & Yang, C.-P. (1993) · PubMed · Cited by 221
Self-citationDominant effects of tubulin overexpression in Saccharomyces cerevisiae.
Burke, D., Gasdaska, P., & Hartwell, L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1049 · Cited by 189
Holzmayer, T. A., Hilsenbeck, S., Von Hoff, D. D., & Roninson, I. B. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.19.1486 · Cited by 178
Differential distribution of beta-tubulin isotypes in cerebellum.
Burgoyne, R. D., Cambray-Deakin, M. A., Lewis, S. A., Sarkar, S., & Cowan, N. J. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03074.x · Cited by 158
A phosphoglycoprotein associated with taxol resistance in J774.2 cells.
Roy, S. N., & Horwitz, S. B. (1985) · PubMed · Cited by 158
Self-citationClass II tubulin, the major brain β tubulin isotype is polyglutamylated on glutamic acid residue 435
Rüdiger, M., Plessmann, U., Klöppel, K.-D., Wehland, J., & Weber, K. K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81061-p · Cited by 152
Weinstein, B. M., & Solomon, F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5295 · Cited by 142
Haber, M., Burkhart, C. A., Regl, D. L., Madafiglio, J., Norris, M. D., & Horwitz, S. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31269 · Cited by 139
Self-citationThree expressed sequences within the human β-tubulin multigene family each define a distinct isotype
Lewis, S. A., Gilmartin, M. E., Hall, J. L., & Cowan, N. J. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90023-3 · Cited by 133
Expression of a human multidrug resistance gene in ovarian carcinomas.
Bourhis, J., Goldstein, L. J., RIOU, G. F., et al. (1989) · PubMed · Cited by 114
Ranganathan, S., Dexter, D., Benetatos, C. A., Chapman, A. E., Tew, K. D., & Hudes, G. R. (1996) · PubMed · Cited by 113
Removal of .BETA.III Isotype Enhances Taxol Induced Microtubule Assembly.
Lu, Q. R., & Ludueña, R. F. (1993) · Cell Structure and Function · doi:10.1247/csf.18.173 · Cited by 101
Mechanisms of drug resistance in ovarian cancer
Johnson, S. W., Ozols, R. F., & Hamilton, T. C. (2010) · Cancer · doi:10.1002/cncr.2820710224 · Cited by 99
Jaffrézou, J., Dumontet, C., Derry, W. B., Durán, G. E., Chen, K. G., Tsuchiya, E., Wilson, L., Jordan, M. A., & Sikic, B. I. (1995) · PubMed · Cited by 82
Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly
Cabral, F., & Barlow, S. B. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.5.2646163 · Cited by 75
Phosphorylation of βIII-Tubulin
KHAN, I. A., & Ludueña, R. F. (1996) · Biochemistry · doi:10.1021/bi951247p · Cited by 74
A Mechanism of Cellular Resistance to Drugs that Interfere with Microtubule Assemblya
Cabral, F. R., Brady, R. C., & Schibler, M. J. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb38456.x · Cited by 72
Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell Line
Ohta, S., Nishio, K., Kubota, N., Ohmori, T., Funayama, Y., Ohira, T., Nakajima, H., Adachi, M., & Saijo, N. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02096.x · Cited by 67
OVARIAN SURFACE EPITHELIUM, OVULATION AND CARCINOGENESIS
Murdoch, W. J. (1996) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.1996.tb01283.x · Cited by 67
Tubulin Isotypes and the Multigene Tubulin Families
Cowan, N. J., & Dudley, L. (1983) · International review of cytology · doi:10.1016/s0074-7696(08)62372-4 · Cited by 61
Day, B. W., Rezenkran, H. S., Gunsekera, Z. S. P., Loungley, R. E., Lin, M. C., Hamel, E., Kowalski, R. P., & Haa, E. (1996) · Cited by 56
Mechanisms of drug resistance in ovarian cancer
Żak, K., Piwoński, M., Stanicki, P., Kalicka, K., & Nowaczek, J. (2021) · Journal of Education Health and Sport · doi:10.12775/jehs.2021.11.09.045 · Cited by 19
Cited by
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Ovarian cancer: strategies for overcoming resistance to chemotherapy
Agarwal, R., & Kaye, S. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1123 · Cited by 1,154
Microtubules and resistance to tubulin-binding agents
Kavallaris, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2803 · Cited by 1,120
Self-citationMechanisms of Taxol resistance related to microtubules
Orr, G. A., Verdier-Pinard, P., McDaid, H., & Horwitz, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206934 · Cited by 727
Self-citationMetronomic chemotherapy: new rationale for new directions
Pasquier, E., Kavallaris, M., & André, N. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.82 · Cited by 659
Self-citation
Metadata
- Authors
- Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M., & Horwitz, S. B.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-09-01
- Volume
- 100
- Issue
- 5
- Pages
- 1282-1293
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2125089526
- Cited by
- 601
- References
- 52
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.